跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 俊彥
講座教授
,
臺北醫學大學癌症轉譯研究中心
主治醫師
,
臺北醫學大學附設醫院
電子郵件
jychang
tmu.edu
tw
,
jychang
nhri.edu
tw
h-index
9879
引文
60
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1985 …
2025
每年研究成果
概覽
指紋
網路
專案
(8)
研究成果
(264)
資料集
(1)
類似的個人檔案
(12)
指紋
查看啟用 Jang-Yang Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
32%
Antimitotic Agent
8%
Antiproliferative Activity
24%
Antitumor Activity
14%
Aurora Kinase Inhibitor
8%
Binding Site
12%
Camptothecin
16%
Carcinogenesis
8%
Cathepsin S
15%
Chemotherapy
14%
Cisplatin
21%
Colchicine
17%
Combretastatin A4
10%
Cytotoxicity
19%
Cytotoxicity
10%
DNA Methyltransferase
8%
DNA Topoisomerase (ATP Hydrolysing)
17%
Drug Resistance
16%
Fluorouracil
17%
Folinic Acid
13%
Gemcitabine
10%
Head and Neck Cancer
20%
Head and Neck Squamous Cell Carcinoma
9%
IC50
44%
Indole
10%
Liver Cell Carcinoma
8%
Lymph Node Metastasis
8%
Malignant Neoplasm
100%
Maximum Tolerated Dose
9%
Methylated DNA Protein Cysteine Methyltransferase
9%
microRNA
12%
Microtubule Inhibitors
18%
Mouse
12%
Mouth Cancer
11%
Mouth Squamous Cell Carcinoma
32%
Nasopharynx Carcinoma
10%
Neoplasm
47%
Oxaliplatin
17%
Paclitaxel
13%
Pancreas Cancer
7%
Pharmacokinetics
12%
Protein P53
9%
Solid Malignant Neoplasm
8%
Squamous Cell Carcinoma
13%
Stomach Cancer
11%
Structure Activity Relationship
11%
Survivin
13%
Transcription Factor Nrf2
10%
Tubulin
50%
Tumor Growth
15%
Medicine and Dentistry
Anticarcinogen
8%
Betel
8%
Camptothecin
9%
Cancer Cell
32%
Cancer Cell Line
6%
Cancer Risk
5%
Carcinogenesis
9%
Cell Migration
8%
Cytotoxicity
7%
Disease
5%
Drug Resistance
7%
Endothelial Cell
5%
Fluorouracil
9%
Folinic Acid
5%
Gemcitabine
5%
Head and Neck Cancer
33%
Head and Neck Squamous Cell Carcinoma
5%
IC50
8%
In Vitro
13%
Lymph Node Metastasis
9%
Malignant Neoplasm
15%
Mesenchymal-Epithelial Transition
5%
Metastatic Carcinoma
6%
microRNA
6%
Microtubule
7%
Microtubule Assembly
5%
Mouth Squamous Cell Carcinoma
33%
Neoplasm
13%
Oral Cancer
15%
Oral Hygiene
6%
Oxaliplatin
8%
Paclitaxel
6%
Signal Transduction
5%
Squamous Cell Carcinoma Cell
10%
Survivin
7%
Transcription Factor Nrf2
5%
Tubulin
9%
Tumor Cell
5%
Biochemistry, Genetics and Molecular Biology
ALDH2
6%
Anticancer
16%
Antineoplastic Activity
7%
Antiproliferative Activity
5%
Binding Site
6%
Cancer Cell
54%
Carcinogenesis
5%
Cathepsin S
5%
Cell Cycle Arrest
5%
Cell Migration
6%
Cisplatin
9%
Cytotoxicity
8%
DNA Methyltransferase
5%
DNA Topoisomerase
7%
down Regulation
10%
Drug Resistance
15%
Eicosanoid Receptor
6%
Epidermal Growth Factor Receptor
6%
IC50
14%
Mesenchymal-Epithelial Transition
8%
Messenger RNA
6%
Methylation
5%
MicroRNA
9%
Microtubule Assembly
9%
Mouse
7%
Piper Betle
7%
Promoter Region
6%
Signal Transduction
7%
STAT3
6%
Topoisomerase
7%
Transforming Growth Factor
5%
Tubulin
14%
Tumor Progression
6%
Tumor Suppressor Protein
6%
Upregulation
8%
Western Blot
6%
